PLoS ONE (Jan 2024)

Correction: Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany.

  • Florian Schwarz,
  • Habibollah Arefian,
  • Michael Hartmann,
  • Ingo Runnebaum

DOI
https://doi.org/10.1371/journal.pone.0303776
Journal volume & issue
Vol. 19, no. 5
p. e0303776

Abstract

Read online

[This corrects the article DOI: 10.1371/journal.pone.0278460.].